Despite the U.S. spending roughly a fourth of GDP on healthcare, the wellness of Americans is still lagging. With 80% of an individual’s health being driven by outside factors of traditional healthcare, benefits leaders are narrowing in on Social Determinants of Health to change the trajectory of the health of their populations.
How Specialty Drugs Affect Your Rx Spend (And What You Can Do About It)
Experts are estimating that specialty Rx will account for 50% of total spending by 2018. Let’s take a closer look at this segment of spending and how employers can help stop the rising tide.
Artemis Health Secures $16 Million Series B Round to Equip Employers with Actionable Employment Benefits Data
Artemis Health received $16 million in Series B funding led by F-Prime Capital (the venture capital funds of FMR LLC, the parent company of Fidelity Investments), with participation from previous investors Maverick Ventures and Kickstart Seed Fund. This is the second major round of funding Artemis Health has raised in 12 months.
How Artemis is Working with Hospitals to Address their Data Challenges
Artemis Health is finding more and more hospitals are interested in optimizing their benefits using data. They’re seeking transparency tools, easy data analysis, and the means to find waste in their spending.
Evaluating a Data Warehouse – How To Get It Right.
The most expensive software you will ever purchase is the software that no one uses. Artemis Health wants to help you find the right data warehouse for your benefits team, employees, and organization.
Three Ways Employers are Using Population Behavior Insights to Drive Value
Employers want to know how their members are engaging with their benefit programs. Let’s take a look at three ways companies are using benefits data to look at employee behavior.
Infertility Benefits: What Employers Should Know
Did you know that 1 in 8 couples will experience infertility? Artemis Health talks to many employers who would like to cover infertility expenses for their population. Their biggest hurdle? They’re not sure how to justify the potential costs.